Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New formulation of CGP-41251

July 26, 1996

Tyrosine kinase inhibitors in Pharmacia & Upjohn's pipeline

July 26, 1996

Octapeptide neuromedin B antagonists described

July 26, 1996

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Aphton announces commencement of phase III trials for Gastrimmune

July 26, 1996

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

Suppressin from pituitary extract described by the University of Alabama

July 19, 1996

Cell-cell adhesion-regulating proteins as antitumor treatment

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...